Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.8%

4 terminated out of 41 trials

Success Rate

81.8%

-4.8% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

22%

4 of 18 completed with results

Key Signals

4 with results82% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (10)
P 1 (10)
P 2 (6)
P 3 (1)
P 4 (1)

Trial Status

Completed18
Not Yet Recruiting5
Terminated4
Recruiting4
Unknown3
Withdrawn3

Trial Success Rate

81.8%

Benchmark: 86.6%

Based on 18 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT02639325Recruiting

Tumor Related Epilepsy

NCT07826949Phase 1Not Yet Recruiting

A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

NCT06630338Not Yet Recruiting

Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements

NCT01503086Not ApplicableCompletedPrimary

Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

NCT07772323Not Yet Recruiting

Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury

NCT03606161Not ApplicableActive Not RecruitingPrimary

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

NCT04810871Not ApplicableSuspendedPrimary

Surgical Resection of Latent Brain Tumors Prior to Recurrence

NCT07699172Not ApplicableNot Yet Recruiting

EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors

NCT02861898Phase 1Recruiting

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

NCT02754544Not ApplicableRecruitingPrimary

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

NCT04553757Active Not RecruitingPrimary

Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

NCT05087888TerminatedPrimary

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

NCT02800486Phase 2Recruiting

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

NCT07286396Not Yet RecruitingPrimary

Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients

NCT05516485Not ApplicableWithdrawnPrimary

Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography

NCT06753617Not ApplicableEnrolling By InvitationPrimary

Cryoablation of Brain Neoplasm

NCT04132843Not ApplicableCompletedPrimary

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

NCT03234309Phase 2WithdrawnPrimary

Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors

NCT00747253Phase 1Completed

Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors

NCT02798406Phase 2Completed

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Scroll to load more

Research Network

Activity Timeline